Results 101 to 110 of about 175,359 (294)
Intelligent Theranostic Systems Enabled by Aggregation‐Induced Emission in Precision Medicine
Aggregation‐induced emission (AIE) luminogens are driving a new generation of intelligent theranostic systems that integrate high‐fidelity imaging and multifunctional therapy. This review highlights how AIEgens, through restriction of intramolecular motion (RIM), enable deep‐tissue NIR‐II imaging, ultrasensitive biosensing, CRISPR‐assisted gene ...
Qinqin Huang +7 more
wiley +1 more source
Abstract Efficient production of 5‐hydroxymethylfurfural (HMF) from glucose was achieved in a water‐methyl isobutyl ketone biphasic solvent system over AlCl3 catalyst, using a green and cheap choline chloride (ChCl) salt as a promoter. An optimized HMF yield of 67% was obtained from 0.6 M glucose over 0.06 M AlCl3 with 3.8 M ChCl addition at 140°C ...
Chencong Ruan, Hero Jan Heeres, Jun Yue
wiley +1 more source
BackgroundChronic kidney disease (CKD) is often accompanied by alterations in the metabolic profile of the body, yet the causative role of these metabolic changes in the onset of CKD remains a subject of ongoing debate.
Yu Yin +14 more
doaj +1 more source
MANNOSE UTILIZATION IN MAN* [PDF]
Francis C. Wood, George F. Cahill
openaire +3 more sources
A novel machine learning approach classifies macrophage phenotypes with up to 98% accuracy using only nuclear morphology from DAPI‐stained images. Bypassing traditional surface markers, the method proves robust even on complex textured biomaterial surfaces. It offers a simpler, faster alternative for studying macrophage behavior in various experimental
Oleh Mezhenskyi +5 more
wiley +1 more source
ENZYMATIC PATTERNS OF ADAPTATION TO FRUCTOSE, GLUCOSE, AND MANNOSE EXHIBITED BY PSEUDOMONAS AERUGINOSA [PDF]
R. G. Eagon, Anita Williams
openalex +1 more source
Metabolism‐Regulating Nanomedicines for Cancer Therapy
This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley +1 more source
Basis for the Mutational Acquisition of the Ability of Aerobacter aerogenes to Grow on
Joseph W. Mayo, Richard L. Anderson
openalex +1 more source
Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease
Peptide/antibody–drug conjugates (PADCs) combine ligand specificity and cleavable linkers to deliver drugs precisely to disease sites with minimal toxicity. While current approvals focus on oncology, this review examines their untapped potential in inflammatory diseases, detailing mechanisms of targeted delivery and highlighting advances that position ...
Yeongji Jang +5 more
wiley +1 more source
Hepatic endothelial Alk1 signaling protects from development of vascular malformations while maintaining organ‐specific endothelial differentiation and angiocrine portmanteau of the names Wingless and Int‐1 signaling. Abstract Background and Aims In hereditary hemorrhagic telangiectasia (HHT), severe liver vascular malformations are associated with ...
Christian David Schmid +20 more
wiley +1 more source

